12/23/24 – Epirium Bio Announces FDA Clearance of IND Application for MF-300 and Appointment of Alex Casdin as New CEO and Russell Cox as Executive Chairman

Epirium Bio Inc published this content on December 23, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 04, 2026 at 06:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]